rs1042512
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001278116.2(L1CAM):c.855C>T(p.Ala285=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00578 in 1,210,597 control chromosomes in the GnomAD database, including 265 homozygotes. There are 1,873 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.030 ( 133 hom., 913 hem., cov: 24)
Exomes 𝑓: 0.0033 ( 132 hom. 960 hem. )
Consequence
L1CAM
NM_001278116.2 synonymous
NM_001278116.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.20
Genes affected
L1CAM (HGNC:6470): (L1 cell adhesion molecule) The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant X-153870192-G-A is Benign according to our data. Variant chrX-153870192-G-A is described in ClinVar as [Benign]. Clinvar id is 158796.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153870192-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0984 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
L1CAM | NM_001278116.2 | c.855C>T | p.Ala285= | synonymous_variant | 9/29 | ENST00000370060.7 | NP_001265045.1 | |
L1CAM | NM_000425.5 | c.855C>T | p.Ala285= | synonymous_variant | 8/28 | NP_000416.1 | ||
L1CAM | NM_024003.3 | c.855C>T | p.Ala285= | synonymous_variant | 8/27 | NP_076493.1 | ||
L1CAM | NM_001143963.2 | c.840C>T | p.Ala280= | synonymous_variant | 7/26 | NP_001137435.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
L1CAM | ENST00000370060.7 | c.855C>T | p.Ala285= | synonymous_variant | 9/29 | 5 | NM_001278116.2 | ENSP00000359077 | A1 | |
L1CAM | ENST00000361699.8 | c.855C>T | p.Ala285= | synonymous_variant | 8/27 | 1 | ENSP00000355380 | P4 | ||
L1CAM | ENST00000361981.7 | c.840C>T | p.Ala280= | synonymous_variant | 7/26 | 1 | ENSP00000354712 | A1 | ||
L1CAM | ENST00000370055.5 | c.840C>T | p.Ala280= | synonymous_variant | 8/27 | 5 | ENSP00000359072 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0297 AC: 3346AN: 112761Hom.: 133 Cov.: 24 AF XY: 0.0260 AC XY: 906AN XY: 34903
GnomAD3 genomes
AF:
AC:
3346
AN:
112761
Hom.:
Cov.:
24
AF XY:
AC XY:
906
AN XY:
34903
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00806 AC: 1474AN: 182899Hom.: 51 AF XY: 0.00510 AC XY: 344AN XY: 67403
GnomAD3 exomes
AF:
AC:
1474
AN:
182899
Hom.:
AF XY:
AC XY:
344
AN XY:
67403
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00332 AC: 3641AN: 1097783Hom.: 132 Cov.: 33 AF XY: 0.00264 AC XY: 960AN XY: 363183
GnomAD4 exome
AF:
AC:
3641
AN:
1097783
Hom.:
Cov.:
33
AF XY:
AC XY:
960
AN XY:
363183
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0297 AC: 3352AN: 112814Hom.: 133 Cov.: 24 AF XY: 0.0261 AC XY: 913AN XY: 34966
GnomAD4 genome
AF:
AC:
3352
AN:
112814
Hom.:
Cov.:
24
AF XY:
AC XY:
913
AN XY:
34966
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 01, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Feb 18, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2014 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Hereditary spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Apr 01, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: -19
Find out detailed SpliceAI scores and Pangolin per-transcript scores at